SAMA THERAPEUTICS

SAAS (software as a service) featuring software using artificial intelligence for machine-learning to synthesize and validate predictive biomarkers grounded in neural, physiological, multi-omics, and behavioral phenotypes for the purpose of more accurately identifying neuropsychiatric disorders for research and development in the field of neuroscience and related drug and medical devices